HPBCD and SBEBCD as therapeutic agents for the treatment of ulcerative collitis
Ulcerative colitis (UC), a major subtype of inflammatory bowel disease (IBD) alongside Crohn’s disease, is characterized by a relapsing and
Tag: inflammatory bowel disease
Covalent cyclodextrin framework for targeted therapy of inflammatory bowel disease
The incidence and prevalence of inflammatory bowel disease (IBD) are steadily rising worldwide, where the pathogenesis and progression are intrinsically